NCT03393377View on ClinicalTrials.gov

Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2017

Conditions
Atherosclerosis
Interventions
DRUG

fluvastatin 10 mg and valsartan 20 mg

DRUG

placebo

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT03393377 - Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination | Biotech Hunter | Biotech Hunter